Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | DUT | P33316 | 6/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25183491 | 0.83 | PKM (0.52) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL30087060 | 0.78 | CRBN (0.46) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL18457159 | 0.78 | CRBN (0.46) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL725455 | 0.76 | CRBN (0.43) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL20850213 | 0.76 | CRBN (0.47) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL27663547 | 0.75 | PKM (0.50) | CRBNPOLBHSD17B10PKMDUT | |
| SCHEMBL28488142 | 0.75 | CRBN (0.42) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL23351432 | 0.75 | CRBN (0.46) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL13609626 | 0.74 | CRBN (0.42) | CRBNPOLBHSD17B10PKMDDB1 | |
| SCHEMBL25583964 | 0.74 | POLB (0.52) | CRBNPOLBHSD17B10PKMDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021072167-A1 | COMPOSITIONS AND METHODS FOR IN VIVO SYNTHESIS OF UNNATURAL POLYPEPTIDES | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-04-15 | — | — | WO | claimed |
| EP-3732187-A1 | UNNATURAL BASE PAIR COMPOSITIONS AND METHODS OF USE | The Scripps Research Institute (US) | 2020-11-04 | — | — | EP | claimed |
| EP-3475295-A1 | NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | The Scripps Research Institute (US) | 2019-05-01 | — | — | EP | claimed |
| WO-2017223528-A1 | NOVEL NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-12-28 | — | — | WO | claimed |
| WO-2017106767-A1 | PRODUCTION OF UNNATURAL NUCLEOTIDES USING A CRISPR/CAS9 SYSTEM | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-06-22 | — | — | WO | claimed |
| WO-2016126987-A1 | COMPOSITIONS AND METHODS FOR SYNTHETIC GENE ASSEMBLY | Twist Bioscience Corporation (US) | 2016-08-11 | — | — | WO | claimed |
| WO-2016115168-A1 | INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF | Synthorx, Inc. (US) | 2016-07-21 | — | — | WO | claimed |
| EP-1308511-A1 | Use of angiopoietin-like 1 and angiopoietin-like 2 nucleic acids and proteins for the treatment of blood-related disorders and defects in vasculature. | Mermaid Pharmaceuticals GmbH (DE) | 2003-05-07 | — | — | EP | claimed |
| WO-2026107352-A1 | COMPOSITIONS AND METHODS FOR EFFICIENT NUCLEIC ACID ASSEMBLY AND TISSUE ENGINEERING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2025235563-A1 | EPIGENETIC MODULATION FOR UPREGULATION OF GENES | OMEGA THERAPEUTICS, INC. (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20250327112-A1 | CIRCULATING BIOMARKER ASSAY FOR BREAST CANCER PREDICTION | UNIV OKLAHOMA (US) | 2025-10-23 | — | — | US | disclosed |
| WO-2025151743-A1 | DENDRIMER-BASED LIPID NANOPARTICLES FOR ORGAN-SELECTIVE MRNA TRANSFECTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2025-07-17 | — | — | WO | disclosed |
| EP-4569116-A2 | IDENTIFICATION OF ALLELE-SPECIFIC TARGET SEQUENCES FOR C9ORF72 | The University of Massachusetts (US) | 2025-06-18 | — | — | EP | disclosed |
| EP-4555102-A1 | SCALABLE, SUBMICRON-RESOLUTION REPLICATION OF DNA ARRAYS | Topogene Inc. (US) | 2025-05-21 | — | — | EP | disclosed |
| WO-1999051741-A2 | LYST PROTEIN COMPLEXES AND LYST INTERACTING PROTEINS | CURAGEN CORPORATION (US) | 1999-10-14 | — | — | WO | disclosed |
| WO-1999050298-A1 | GFRα-X, A NOVEL GLIAL-DERIVED NEUROTROPHIC FACTOR RECEPTOR AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-10-07 | — | — | WO | disclosed |
| WO-1998046756-A9 | SECRETED PROTEIN SSP-1 COMPOSITIONS AND THERAPEUTIC AND DIAGNOSTIC USES THEREFOR | — | 1999-03-11 | — | — | WO | disclosed |
| WO-1998046756-A1 | SECRETED PROTEIN SSP-1 COMPOSITIONS AND THERAPEUTIC AND DIAGNOSTIC USES THEREFOR | MILLENNIUM BIOTHERAPEUTICS (US) | 1998-10-22 | — | — | WO | disclosed |
| EP-0817798-A1 | NUCLEOTIDE AND PROTEIN SEQUENCES OF LATS GENES AND METHODS BASED THEREON | YALE UNIVERSITY (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030402-A1 | NUCLEOTIDE AND PROTEIN SEQUENCES OF LATS GENES AND METHODS BASED THEREON | YALE UNIVERSITY (US) | 1996-10-03 | — | — | WO | disclosed |